tracker

TQMC

TQMC has acquired wide Domain Knowledge and Experience. You can FREELY access it here and here

DISCLAIMER: This matter here is a guide only. For authentic and up-to-date information, please contact TQMC.

The DIRECTIVES and STANDARDS listed here may have been subsequently REVISED . You must refer to the CURRENT REVISION and AMENDMENTS if any.

Wednesday, September 30, 2009


  • More

.reelContentTree .unitList", panel: "li", viewArea: 4}, carousel: {navContainer: ".reelNav", prevButton: ".newsreel_prev", nextButton: ".newsreel_next", type: "circular"}}}" style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; font-size: 1em; ">
  • SEPTEMBER 30, 2009, 4:21 A.M. ET

UPDATE: Dr Reddy's Voluntarily Recalls Some Products From US

MORE IN BUSINESS »

(Adds analyst comment, share price, background.)

By Rumman Ahmed

Of DOW JONES NEWSWIRES

BANGALORE (Dow Jones)--India's Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday the company is voluntarily recalling four products from the U.S. market as a precaution as some lots contained oversized tablets.

Dr. Reddy's is recalling citalopram 40 milligram in bottles of 100 tablets, fexofenadine ...

Add a Comment

All comments will display your real name.
Want to participate in the discussion?

Or log in or become a subscriber now for complete Journal access.

  • CLEAR
  • POST
Email Newsletters and alerts

Most Popular In India

Posted by at

1 comment:

Subscribe to: Post Comments (Atom)